These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 24502610)

  • 1. Association between circulating adiponectin levels and polycystic ovarian syndrome.
    Mirza SS; Shafique K; Shaikh AR; Khan NA; Anwar Qureshi M
    J Ovarian Res; 2014 Feb; 7():18. PubMed ID: 24502610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-molecular-weight adiponectin is inversely associated with sympathetic activity in polycystic ovary syndrome.
    Shorakae S; Abell SK; Hiam DS; Lambert EA; Eikelis N; Jona E; Sari CI; Stepto NK; Lambert GW; de Courten B; Teede HJ
    Fertil Steril; 2018 Mar; 109(3):532-539. PubMed ID: 29428305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma adiponectin and insulin resistance in women with polycystic ovary syndrome.
    Ardawi MS; Rouzi AA
    Fertil Steril; 2005 Jun; 83(6):1708-16. PubMed ID: 15950640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma adiponectin levels in women with polycystic ovary syndrome: impact of metformin treatment in a case-control study.
    Singh S; Akhtar N; Ahmad J
    Diabetes Metab Syndr; 2012; 6(4):207-11. PubMed ID: 23199540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The high-molecular weight multimer form of adiponectin is a useful marker of polycystic ovary syndrome in Bahraini Arab women.
    Al-Awadi AM; Sarray S; Arekat MR; Saleh LR; Mahmood N; Almawi WY
    Clin Nutr ESPEN; 2016 Jun; 13():e33-e38. PubMed ID: 28531566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum resistin and adiponectin levels in young non-obese women with polycystic ovary syndrome.
    Arikan S; Bahceci M; Tuzcu A; Kale E; Gökalp D
    Gynecol Endocrinol; 2010 Mar; 26(3):161-6. PubMed ID: 20148738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoadiponectinemia: a useful marker of dyslipidemia in women with polycystic ovary syndrome.
    Chang CY; Chen MJ; Yang WS; Yeh CY; Ho HN; Chen SU; Yang YS
    Taiwan J Obstet Gynecol; 2012 Dec; 51(4):583-90. PubMed ID: 23276562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin resistance and its relationship with high molecular weight adiponectin in adolescents with polycystic ovary syndrome and a maternal history of polycystic ovary syndrome.
    Cankaya S; Demir B; Aksakal SE; Dilbaz B; Demirtas C; Goktolga U
    Fertil Steril; 2014 Sep; 102(3):826-30. PubMed ID: 24973036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are serum chemerin levels different between obese and non-obese polycystic ovary syndrome women?
    Yang S; Wang Q; Huang W; Song Y; Feng G; Zhou L; Tan J
    Gynecol Endocrinol; 2016; 32(1):38-41. PubMed ID: 26291816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin resistance and high molecular weight adiponectin in obese and non-obese patients with Polycystic Ovarian Syndrome (PCOS).
    Shirazi FKH; Khodamoradi Z; Jeddi M
    BMC Endocr Disord; 2021 Mar; 21(1):45. PubMed ID: 33750349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. L:A ratio, Insulin resistance and metabolic risk in women with polycystic ovarian syndrome.
    Gupta V; Mishra S; Mishra S; Gupta V
    Diabetes Metab Syndr; 2017 Dec; 11 Suppl 2():S697-S701. PubMed ID: 28529126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimüllerian hormone levels and cardiometabolic risk in young women with polycystic ovary syndrome.
    Feldman RA; O'Neill K; Butts SF; Dokras A
    Fertil Steril; 2017 Jan; 107(1):276-281. PubMed ID: 27842995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of serum adiponectin levels in women with polycystic ovarian syndrome.
    Itoh H; Kawano Y; Furukawa Y; Matsumoto H; Yuge A; Narahara H
    Clin Exp Obstet Gynecol; 2013; 40(4):531-5. PubMed ID: 24597249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lower circulating levels of CTRP12 and CTRP13 in polycystic ovarian syndrome: Irrespective of obesity.
    Shanaki M; Moradi N; Fadaei R; Zandieh Z; Shabani P; Vatannejad A
    PLoS One; 2018; 13(12):e0208059. PubMed ID: 30540803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low plasma atrial natriuretic peptide: a new piece in the puzzle of polycystic ovary syndrome.
    Lauria PB; Del Puerto HL; Reis AM; Candido AL; Reis FM
    J Clin Endocrinol Metab; 2013 Dec; 98(12):4882-9. PubMed ID: 24057296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case-control study of correlation between serum adiponectin levels and polycystic ovary syndrome].
    Li H; Chen Y; Li Y; Huang J; Zhao X; Chen X; Yang D
    Zhonghua Fu Chan Ke Za Zhi; 2015 Nov; 50(11):814-8. PubMed ID: 26887767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of adiponectin multimeric forms in Chinese women with polycystic ovary syndrome and their relation to insulin resistance.
    Tao T; Wickham EP; Fan W; Yang J; Liu W
    Eur J Endocrinol; 2010 Sep; 163(3):399-406. PubMed ID: 20530094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum resistin and adiponectin levels in women with polycystic ovary syndrome.
    Yilmaz M; Bukan N; Demirci H; Oztürk C; Kan E; Ayvaz G; Arslan M
    Gynecol Endocrinol; 2009 Apr; 25(4):246-52. PubMed ID: 19408174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioavailable and free 25-hydroxyvitamin D and vitamin D binding protein in polycystic ovary syndrome: Relationships with obesity and insulin resistance.
    Naderpoor N; Shorakae S; Abell SK; Mousa A; Joham AE; Moran LJ; Stepto NK; Spritzer PM; Teede HJ; de Courten B
    J Steroid Biochem Mol Biol; 2018 Mar; 177():209-215. PubMed ID: 28734987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adiponectin and leptin in overweight/obese and lean women with polycystic ovary syndrome.
    Chen CI; Hsu MI; Lin SH; Chang YC; Hsu CS; Tzeng CR
    Gynecol Endocrinol; 2015 Apr; 31(4):264-8. PubMed ID: 25423261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.